Research Paper Volume 16, Issue 7 pp 5866—5886
NXPH4 can be used as a biomarker for pan-cancer and promotes colon cancer progression
Figure 1. Abnormal expression and diagnostic ability of NXPH4 in pan-cancer. (A) Differential expression of NXPH4 between pan-cancer and corresponding normal tissues in TCGA combined GTEx database. (B) Differential expression of NXPH4 in early and late cancer tissues of BRCA, CESC, COAD, and LIHC. (C) Diagnostic ROC curve of NXPH4 in pan-cancer.